XM does not provide services to residents of the United States of America.

Admiral, Capgemini, Zurich Insurance Group



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>EUROPE RESEARCH ROUNDUP- Admiral, Capgemini, Zurich Insurance Group</title></head><body>

Aug 22 (Reuters) -Securities analysts revised their ratings and price targets on several European companies, including Admiral, Capgemini and Zurich Insurance Group, on Thursday.

HIGHLIGHTS


* Admiral ADML.L: Jefferies raises to hold from underperform

* Capgemini CAPP.PA: Jefferies cuts target price to EUR 185 from EUR 195

* Glenveagh Properties Plc GLV.I: Jefferies raises to buy from hold

* Orsted ORSTED.CO: Deutsche Bank cuts target price to DKK 470 from DKK 480

* Zurich Insurance Group AG ZURN.S: Morgan Stanley cuts PT to CHF 486 from CHF 490

Following is a summary of research actions on European companies reported by Reuters on Thursday. Stock entries are in alphabetical order.


* Admiral ADML.L: Jefferies raises PT to 3,025p from 2,300p

* Admiral ADML.L: Jefferies raises to hold from underperform

* Alcon AG ALCC.S: BofA Global Research raises price objective to CHF 85 from CHF 80

* Alcon AG ALCC.S: JP Morgan cuts target price to CHF 84.3 from CHF 88.9

* Antofagasta ANTO.L: Bernstein raises target price to 1960p from 1920p

* ASR Nederland NV ASRNL.AS: JP Morgan raises target price to EUR 54 from EUR 53

* Avolta AG AVOL.S: Barclays cuts target price to CHF 45 from CHF 50

* Benevolentai BAI.AS: Deutsche Bank initiates coverage with buy rating and PT EUR 2.7

* Biomerieux SA BIOX.PA: UBS initiates coverage with buy rating; PT EUR 129

* Brenntag SE BNRGn.DE: Morgan Stanley cuts target price to EUR 80 from EUR 88

* Capgemini CAPP.PA: Jefferies cuts target price to EUR 185 from EUR 195

* Carlsberg A/S CARLB.CO: HSBC cuts target price to DKK 950 from DKK 1040

* Coloplast A/S COLOb.CO: Barclays cuts target price to DKK 1005 from DKK 1015

* Deceuninck DCEB.BR: KBC Securities raises to "buy" from "accumulate"

* Derwent London Plc DLN.L: Berenberg raises target price to 2,700p from 2,494p

* Docmorris DOCM.S: Deutsche Bank cuts target price to CHF 45 from CHF 99

* Docmorris DOCM.S: Deutsche Bank cuts to hold from buy

* Engie ENGIE.PA: Morgan Stanley raises target price to EUR 19 from EUR 18

* Glenveagh Properties Plc GLV.I: Jefferies raises PT to EUR 2.25 from EUR 1.52

* Glenveagh Properties Plc GLV.I: Jefferies raises to buy from hold

* Gurit GURN.S: UBS cuts target price to CHF 40 from CHF 65

* H Lundbeck A/S HLUNb.CO: Barclays raises PT to DKK 44 from DKK 40

* H Lundbeck A/S HLUNb.CO: Leerink Partners raises target price to DKK 45 from DKK 35

* Hellofresh SE HFGG.DE: Stifel raises target price to EUR 8 from EUR 7

* Hochtief AG HOTG.DE: Jefferies raises target price to EUR 134 from EUR 124

* ITM Power Plc ITM.L: Panmure Liberum cuts target price to 84p from 90p

* Jyske Bank JYSK.CO: UBS cuts target price to DKK 585 from DKK 600

* Kinepolis Group Plc KIPO.BR: KBC Securities cuts PT to EUR 50 from EUR 53; rating "buy"

* Kingspan Group Plc KSP.I: Jefferies cuts target price to EUR 80.2 from EUR 82.1

* Kingspan Group Plc KSP.I: Morgan Stanley raises target price to EUR 79 from EUR 77

* Kistos Holdings Plc KIST.L: Berenberg raises target price to 300p from 295p

* Maaden 1211.SE: HSBC cuts target price to sar 31 from sar 31.5

* NKT A/S NKT.CO: Barclays raises target price to DKK 574 from DKK 522

* Orsted ORSTED.CO: Deutsche Bank cuts target price to DKK 470 from DKK 480

* Outokumpu Oyj OUT1V.HE: Citigroup cuts target price to EUR 3.5 from EUR 3.7

* Pennon Group Plc PNN.L: UBS raises target price to 890p from 870p

* R&S Group RSGN.S: UBS raises target price to CHF 22 from CHF 14.9

* Salzgitter AG SZGG.DE: Citigroup cuts target price to EUR 17 from EUR 19

* Segro SGRO.L: JP Morgan raises target price to 1,050p from 1,000p

* Siemens Energy AG ENR1n.DE: BofA Global Research raises price objective to EUR 37 from EUR 35

* SSAB AB SSABa.ST: Citigroup cuts target price to SEK 70 from SEK 82

* Tesco TSCO.L: Barclays raises target price to 375p from 350p

* Tessenderlo Group TESB.BR: KBC Securities cuts PT to EUR 32 from EUR 34; rating 'accumulate'

* ThyssenKrupp TKAG.DE: Citigroup cuts target price to EUR 6 from EUR 7

* Unilever ULVR.L: BofA Global Research raises to buy from underperform

* Unilever ULVR.L: BofA Global Research raises price objective to 5600p from 3800p

* United Utilities UU.L: UBS cuts target price to 1150p from 1180p

* United Utilities UU.L: UBS raises to buy from neutral

* United Utilities UU.L: UBS raises to buy from neutral; cuts PT to 1,150p from 1,180p

* Voestalpine AG VOES.VI: Citigroup cuts target price to EUR 24 from EUR 28

* Ypsomed Holding AG YPSN.S: UBS initiates coverage with neutral rating; PT CHF 430

* Zurich Insurance Group AG ZURN.S: Morgan Stanley cuts PT to CHF 486 from CHF 490


(Compiled by Bengaluru Newsroom)

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.